|
SKIV2L2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.30580032634498E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.34180000443962E-08 |
| Normal-vs-Stage2 |
1.51139999999828E-05 |
| Normal-vs-Stage3 |
1.01389996398638E-09 |
| Normal-vs-Stage4 |
4.84270401557296E-11 |
| Stage1-vs-Stage2 |
5.469200E-01 |
| Stage1-vs-Stage3 |
9.174300E-02 |
| Stage1-vs-Stage4 |
5.117000E-03 |
| Stage2-vs-Stage3 |
5.771800E-01 |
| Stage2-vs-Stage4 |
2.263800E-01 |
| Stage3-vs-Stage4 |
3.594800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.45240511126599E-11 |
| Normal-vs-AfricanAmerican |
2.422500E-03 |
| Normal-vs-Asian |
8.19130000051516E-07 |
| Caucasian-vs-AfricanAmerican |
2.650600E-01 |
| Caucasian-vs-Asian |
8.976400E-01 |
| AfricanAmerican-vs-Asian |
3.594000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17350035139441E-10 |
| Normal-vs-Female |
8.63810023510325E-10 |
| Male-vs-Female |
4.436400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.1738000000624E-07 |
| Normal-vs-Age(41-60Yrs) |
6.68169963802256E-10 |
| Normal-vs-Age(61-80Yrs) |
1.37289957180542E-10 |
| Normal-vs-Age(81-100Yrs) |
4.859200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.560200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.842100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.887000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.903600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.883000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.627400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.952200E-02 |
| Classical-VS-Follicular |
1.693030E-01 |
| Classical-VS-Other |
2.458000E-01 |
| Classical-VS-Normal |
6.31940000328512E-09 |
| Tall-VS-Follicular |
5.260800E-01 |
| Tall-VS-Other |
7.513000E-01 |
| Tall-VS-Normal |
2.69619999992976E-07 |
| Follicular-VS-Other |
6.022200E-01 |
| Follicular-VS-Normal |
1.57799999955799E-07 |
| Other-VS-Normal |
1.819650E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.21590004731331E-09 |
| Normal-vs-N1 |
9.87890003134595E-09 |
| N0-vs-N1 |
4.216400E-01 |
|
|
